Orlando, FL -- (SBWIRE) -- 10/02/2013 -- Hot Stock Profits provides investors and traders with valuable trading tools and content as well as micro-cap stock alerts via eMail and text messages. To Join Our Text Message Alerts Service Just Text The Word Stocks To 555888 From Your Cell Phone. Our Focus Today Is On Progenics Pharmaceuticals, Inc.(NASDAQ:PGNX), Allied Nevada Gold Corp. (NYSEAMEX:ANV).
Progenics Pharmaceuticals, Inc.(NASDAQ:PGNX) shares decreased 4.98% to $4.77. Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) and Progenics Pharmaceuticals on Oct. 1 announced that the FDA will convene an Advisory Committee on March 10-11, 2014 at which time Salix's Supplemental New Drug Application (sNDA) for RELISTOR® (methylnaltrexone bromide) Subcutaneous Injection, for opioid-induced constipation, or OIC, in patients with chronic pain will be considered. The date and agenda for the Advisory Committee will not be definitive until publication in the Federal Register.
The FDA's action to convene an Advisory Committee was taken in response to the formal appeal by Salix of the complete response action taken by the FDA on July 27, 2012 regarding the RELISTOR sNDA for chronic pain.
Are investors worried about the recent updates with PGNX? Find out with a free trend analysis HERE
Allied Nevada Gold Corp. (NYSEAMEX:ANV) shares decreased 4.78% to $3.98. ANV’s stock was upgraded by Zacks from an “underperform” rating to a “neutral” rating in a note issued to investors on Sept. 24. The firm currently has a $4.70 price target on the stock. Zacks‘ target price indicates a potential upside of 2.62% from the stock’s previous close.
Is ANV going to continue its rally or drop like a rock? Find out with a free trend analysis HERE
Join Our Mobile SMS Alerts By Texting Stocks To 555888
HotStockProfits.com continuously monitors and scans the markets for day trading and swing trading signals on NASDAQ, NYSE, AMEX, OTCBB and Pink Sheet companies for its free e-newsletter subscribers.
HotStockProfits.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit HotStockProfits.com website, for complete risks and disclosures.
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)